On June 17, 2025, PTC Therapeutics, Inc. held its Annual Meeting where stockholders elected three directors and ratified the appointment of Ernst & Young LLP as their accounting firm with the majority votes. The meeting results included 60,386,986 votes for Allan Jacobson, 59,200,375 for David P. Southwell, and 54,894,657 for Alethia Young, along with a non-binding advisory proposal on executive compensation that received 60,479,157 votes in favor.